Lineage Cell Therapeutics (LCTX) Long-Term Deferred Tax (2013 - 2026)
Lineage Cell Therapeutics (LCTX) posted quarterly Long-Term Deferred Tax of $5.8 million for Q1 2026, little changed quarter-over-quarter from $5.8 million in Q4 2025.
Lineage Cell Therapeutics (LCTX) Long-Term Deferred Tax (2013 - 2026) Analysis & Trends
Lineage Cell Therapeutics' Long-Term Deferred Tax history runs 10 years deep, the most recent figure standing at $5.8 million for Q1 2026.
- In Q1 2026, Long-Term Deferred Tax changed N/A year-over-year to $5.8 million; the TTM figure through Mar 2026 stood at $5.8 million (changed N/A YoY), while the FY2025 annual figure was $5.8 million, up 2024.54% from the prior year.
- Long-Term Deferred Tax for Q1 2026 stood at $5.8 million, roughly flat from $5.8 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $5.8 million in Q4 2025, with the low at $273000.0 in Q4 2024.
- The 3-year median for Long-Term Deferred Tax is $5.8 million (2025), against an average of $4.0 million.
- Peak annual rise in Long-Term Deferred Tax reached 2024.54% in 2025, while the deepest fall reached 2024.54% in 2025.
- Lineage Cell Therapeutics' Long-Term Deferred Tax stood at $273000.0 in 2024, then jumped by 2024.54% to $5.8 million in 2025, then changed by 0.0% to $5.8 million in 2026.
- Business Quant data shows LCTX's Long-Term Deferred Tax at $5.8 million in Q1 2026, $5.8 million in Q4 2025, and $273000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Lineage Cell Therapeutics | 270.61 Mn | 212.77 Mn | 1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.80 Mn |
| Mar 31, 2026 | 5.80 Mn |
| Dec 31, 2025 | 5.80 Mn |
| Dec 31, 2024 | 273,000.00 |
| Dec 31, 2020 | 2.08 Mn |
| Dec 31, 2019 | 56.28 Mn |
| Dec 31, 2018 | 37.76 Mn |
| Dec 31, 2017 | 8.90 Mn |
| Dec 31, 2016 | 78,116.00 |
| Sep 30, 2014 | 5.18 Mn |
| Jun 30, 2014 | 2.86 Mn |
| Mar 31, 2014 | 1.35 Mn |
| Dec 31, 2013 | 3.28 Mn |